Anjali Cremer
Goethe University Frankfurt(DE)University Hospital Frankfurt(DE)Frankfurt Cancer Institute(DE)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Childhood Cancer Survivors' Quality of Life, Protein Degradation and Inhibitors, Pharmaceutical studies and practices
Most-Cited Works
- → SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia(2016)179 cited
- → The proteogenomic subtypes of acute myeloid leukemia(2022)136 cited
- → Hoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling by Suppressing miR-146a in Acute Myeloid Leukemia(2017)113 cited
- → FLT3-ITD and TLR9 use Bruton tyrosine kinase to activate distinct transcriptional programs mediating AML cell survival and proliferation(2015)56 cited
- → IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemia(2022)56 cited
- → Virtual Screening Identifies Irreversible FMS-like Tyrosine Kinase 3 Inhibitors with Activity toward Resistance-Conferring Mutations(2019)42 cited